Friday, July 10, 2026

Drug profile · INN

aminohippurate sodium

aminohippurate sodium (AMINOHIPPURATE SODIUM) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — aminohippurate sodium
US status
approved
Class
Route
INJECTION
Patents
0
Programs
0
Data quality
0.84

Quick answer

aminohippurate sodium (AMINOHIPPURATE SODIUM) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN aminohippurate sodium
Brand AMINOHIPPURATE SODIUM
Route INJECTION
Formulation INJECTABLE

Approval history

Authority Status Date
FDA approved

Frequently asked questions

What is aminohippurate sodium?

aminohippurate sodium (AMINOHIPPURATE SODIUM) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for aminohippurate sodium?

AMINOHIPPURATE SODIUM is a marketed brand name for aminohippurate sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of aminohippurate sodium?

aminohippurate sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.